The aim of the present study was, therefore, to evaluate the impact of SGLT2 and glucose concentration levels on the progression of ccRCC with the VHL mutation using in vitro models that were not subject to the many potential confounders linked to DM in vivo. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.